Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TPST Tempest Therapeutics, Inc. 8-K

Tempest raises $2M by slashing warrant price 51%, issues new warrants for 2.3M shares

Filed June 2, 2026 · Period ending May 28, 2026 · ~1 min read

Key Changes

  • high

    Company induced warrant exercise by cutting price from $3.50 to $1.73 per share, raising ~$2M gross but issuing new warrants for twice as many shares (2.3M), creating significant future dilution risk.

  • high

    New warrants expire May 2028 and require shareholder approval before becoming exercisable. Include cashless exercise rights if shares aren't registered, meaning company may not receive cash from future exercises.

  • medium

    Placement agent receives cascading compensation: immediate warrants for 82K shares plus 7% cash fee and 7% additional warrants on any new warrant exercises within 24 months, compounding dilution.

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify